Only 7 left in stock (more on the way).
Ships from and sold by Gift-wrap available.
The Baby Business: How Mo... has been added to your Cart
+ CDN$ 6.49 shipping
Used: Very Good | Details
Condition: Used: Very Good
Comment: Ships from the USA. Please allow 14-21 business days for delivery. Ex-Library Book - will contain Library Markings. Very good condition book with only light signs of previous use. Sail the Seas of Value.
Have one to sell?
Flip to back Flip to front
Listen Playing... Paused   You're listening to a sample of the Audible audio edition.
Learn more
See all 2 images

The Baby Business: How Money, Science, and Politics Drive the Commerce of Conception Hardcover – Feb 1 2006

See all 2 formats and editions Hide other formats and editions
Amazon Price
New from Used from
"Please retry"
CDN$ 26.95
CDN$ 10.99 CDN$ 1.00

Unlimited FREE Two-Day Shipping for Six Months When You Try Amazon Student
click to open popover

No Kindle device required. Download one of the Free Kindle apps to start reading Kindle books on your smartphone, tablet, and computer.

  • Apple
  • Android
  • Windows Phone
  • Android

To get the free app, enter your mobile phone number.

Product Details

  • Hardcover: 298 pages
  • Publisher: Harvard Business Review Press; 1 edition (Feb. 1 2006)
  • Language: English
  • ISBN-10: 1591396204
  • ISBN-13: 978-1591396208
  • Product Dimensions: 2.5 x 16.5 x 24.1 cm
  • Shipping Weight: 635 g
  • Average Customer Review: Be the first to review this item
  • Amazon Bestsellers Rank: #634,939 in Books (See Top 100 in Books)
  •  Would you like to update product info, give feedback on images, or tell us about a lower price?

  • See Complete Table of Contents

Product Description

From Publishers Weekly

Among the troubling aspects of new reproductive technologies is the takeover of reproduction by the marketplace. This probing study accepts the free market process while casting a discerning and skeptical eye at its pitfalls. Harvard business prof Spar (The Cooperative Edge: The Internal Politics of International Cartels) explores many aspects of the high-tech commodification of procreation: the fabulous revenues commercial fertility clinics earn from couples' desperate desire for children and the ensuing conflicts between medical ethics and the profit motive; the premiums paid for sperm and eggs from genetically desirable donors; the possible exploitation of poor, nonwhite and Third World surrogate mothers paid to gestate the spawn of wealthy Westerners; the fine line between modern adoption practices and outright baby selling; and the new entrepreneurial paradigm of maternity, in which the official "mother" simply finances the assemblage of sperm, purchased egg and hired womb and lays contractual claim to the finished infant. Spar considers most of these developments inevitable and not undesirable (they provide kids to parents who want them), but calls for government regulation to curb excesses and protect the interests of all involved. Her sanguinity will not satisfy all critics, but she offers a lucid, nuanced guide to this brave new world. (Feb. 14)
Copyright © Reed Business Information, a division of Reed Elsevier Inc. All rights reserved.


"Spar builds a case for some regulation…to ensure that it "manufacture[s] embryos that turn into babies," accessible to all who want them." -- The Globe and Mail, May 27, 2006

See all Product Description

Customer Reviews

There are no customer reviews yet on
5 star
4 star
3 star
2 star
1 star

Most Helpful Customer Reviews on (beta) 4.5 out of 5 stars 12 reviews
10 of 12 people found the following review helpful
5.0 out of 5 stars The Birth of the Scholarly Page Turner March 30 2006
By R. Schmon - Published on
Format: Hardcover
This is good stuff-if not juicy, and Spar casts a wide net that doesn't miss a thing: conception techniques, fertility markets, surrogacy, designer babies, human cloning, and adoption. The writer also has the guts to have a lucid, constructive point of view-never backing away from the controversial subjects many would balk about discussing. This book is a must read for anyone who might, is, or has gone through any of the processes above, and for the rest of us like me, just a great eye-opening read. In fact, I kept thinking as the pages turned: "I had no idea..." As a piece of scholarly writing it is immaculate (check out the pages of footnotes!), but more impressive is the fact that Spar's writing style is trenchant, entertaining and unwavering in it's ability to present a point of view to the reader. I wasn't expecting it, but Spar continually challenges and provokes as she weaves her riveting tale of the dynamics of a topic-both moral and technical-that is dear to the hearts of us all: babies. Wow. A scholarly page-turner!? Shouldn't there be an award for that? It's great read, and I highly recommend it.
19 of 25 people found the following review helpful
3.0 out of 5 stars Mere markets? Sept. 20 2006
By Bill Muehlenberg - Published on
Format: Hardcover
The fact that this book is published by the Harvard Business School and the author is a professor there tells us much about how this topic is broached. The main focus of the book is on how the infertility industry (the baby business) and the market interact. Other vital elements, such as moral considerations, are barely mentioned. And this is where the book breaks down. Yes, the market side to the question is very important, and rightly needs to be explored, but taken out of a bigger social and ethical context, the approach comes across barren and empty (no pun intended).

Spar quickly dismisses ethical concerns, arguing that they are messy, controversial, and incapable of any resolution. Thus her focus is single: to see how the desire for babies fits in with the world of trade and commerce. And her premises are not easily gainsaid: people desire to have babies (and/or baby parts, or services, or technologies) and there are many who are happy to provide these things, especially for a price. It is as simple as that: supply and demand.

Economically speaking, as Spar keeps noting, it is a match made in heaven. This trade in babies is therefore inevitable and here to stay, she argues. The horse has bolted, and there is no going back to the stable now. We must live with the new reproductive technologies, and their inevitable commercialization. The only question is whether the baby market should be open slather, or whether some sort of regulatory scheme should be put in place.

The bulk of this book examines the various areas of the baby trade - be it IVF, surrogacy, sperm and egg selling, cloning and the like - and how money has been invariably linked to the fertility industry.

Of course this book describes the situation in the US, where there is very little government regulation at all over the fertility business. Other nations do have regulatory schemes in place, which the author refers to now and then. But it is the wild west of the American fertility trade that is in focus here.

Spar believes that the market will always be part of this industry, and that it is not a bad thing at all. But she recognizes that as the "product" in discussion is a human baby, many are reluctant to speak of it all in purely financial terms. She occasionally acknowledges the critics, like Leon Kass, who see much of the reproductive industry as involved in the commodification of children and the manufacture of life, but seems little impressed by their concerns.

Indeed, she says early on that the market will always triumph, while issues of morality will remain unresolved, and by implication, be of secondary importance. Thus she simply accepts the reproductive revolution and Big Biotech as necessary, inevitable forces that will not go away. Don't worry about the ethical concerns, she seems to suggest. Instead, given the inevitability of the market in this area, the only real issue is what kind of regulation, if any, do we want applied. The topic of regulation she only addresses briefly, and in her final chapter.

She in fact claims not to have any clear answers here. She does state her preference, a "light-handed regulatory regime" in which choice, information and costs are considered. She recognizes that there may be a dark side to an unchecked market, especially in some of the `yuk' areas like human cloning, but she seems to think the market as a whole, with a little help from the government, will largely get things right.

Thus she is optimistic about both the science and economics of the reproductive revolution. Many others, of course, are worried about the brave new world implications of where all this is headed. Spar here and there acknowledges these concerns, but generally sees them as irrelevant or of no great consequence. Of course such considerations are too controversial for many to even raise. Indeed, free marketers will be squeamish about such discussions. But they are nonetheless part of the equation.

Indeed, the traditional philosophical, spiritual and social implications are as much a part of this discussion as mere market concerns. So for a more inclusive and well-rounded discussion of these issues, the reader needs to go elsewhere.

But if the reader wants a simple overview and history of the new reproductive technologies, and their economic implications, this book is undoubtedly a good place to begin.
9 of 11 people found the following review helpful
5.0 out of 5 stars Insightful treatise on a difficult and emotional topic Feb. 28 2006
By G. Ross - Published on
Format: Hardcover
A very insightful treatise on a very difficult and necessarily emotional topic. For anyone involved in the business of fertility or interested in using non-traditional methods of conception or the adoption of children, a must read. Ms. Spar's book is a frank, detailed plunge into the practices, economies and ethics of the "Baby Business" with conclusions that propose a gentle regulation of reproduction practices.
5.0 out of 5 stars If I had only known .... Oct. 26 2013
By bbempress - Published on
Format: Hardcover Verified Purchase
Ms. Spar's book provides incredible insights into this commercial industry whose revenues are built on the hopes and dreams of building families. I had the pleasure of meeting and hearing Professor Spar speak about her research and insights at a Harvard Business School reunion weekend in 2006 when I was struggling with infertility after our first child and giving up my successful career to support my husband and our family. Ms. Spar's book is an objective assessment of this industry in terms of the key players, its drivers and issues. Very helpful to understand especially if you are dealing with fertility clinics to understand what drives them. I am not big on government regulation in general but the "conception industry" is one where some government oversight could better protect and educate families and those who want to help these families. If I had only known and read Ms. Spar's book before I began our journey, it would have been less heartwrenching. I have consistently recommended this book to my friends and colleagues who are struggling with fertility and considering other means to have children. Our journey ended well as we were blessed with another child -- my verson of "having it all" as an AMA woman ("advanced maternal age" as the doctors labelled me) who waited to have children later in life. Here's to beating the odds and the clock!
1 of 1 people found the following review helpful
5.0 out of 5 stars Honey ... you really don't need to sleep with the maid anymore March 28 2011
By Ashish - Published on
Format: Hardcover Verified Purchase
Indeed. We have come a long way since the Book of Genesis. Today, the market would provide Rachel and Jacob a multitude of choices. They could buy some sperm ([...]), eggs ([...]) or frozen embryos ([...]). They could lease a womb or opt for in-vitro fertilization (IVF); or better yet, IVF with intra-cytoplasmic sperm injection (ICSI) or with pre-implantation genetic diagnosis (PGD). Pretty soon cloning may also be an option, though as of now many of the experiments with sheep and pet cats appear to have gone haywire due to birth defects and premature ageing. `Scientific progress' in the area of assisted reproduction has separated the act of sex from reproduction. In effect, what fertility clinics sell is the process. The components can be sourced from third parties, put together in a laboratory and then transferred to a leased womb through a gestational surrogacy contract. This is probably good - infertile women no longer have to implore their husbands to sleep with the maid. In addition, it has created an upstream market, or one for inputs and components. Presumably this is good too - selling a baby may sound morally reprehensible, but selling sperm or eggs doesn't sound that bad. Sperm is cheap. The average price is about $300. Eggs go for between $2500 and $50000 - the right combination of beauty and brains costs more. What many people find objectionable is that new reproductive technologies provide choice. If people have choice they will exercise it - after all everyone wants the `perfect' baby.

In her fascinating book The Baby Business, Debora Spar lays out all the choices available to present day Rachels and Jacobs. Approximately 15% of women and 10-15% of men in the U.S. have fertility problems. In 2002 about 17% of married women in the U.S. were either infertile or had impaired fecundity. In 1995 there were 6.1 million infertile women in the U.S. and approximately a third of them sought some type of treatment and only 1% sought assisted reproductive treatment. The baby business is big business - excluding adoption and PGD, it was a $3 billion market in the US in 2004 with a third being accounted for by IVF and another third by fertility drugs.

Spar argues that step one is to call a spade a spade. Eggs may be `donated' but donors get compensated in the form of gifts, which include massages and diamond necklaces. Spar writes of an attorney by the name of Noel Keane who started a brokerage business in the surrogacy market in the mid 1970's. At one point Keane tried to eliminate payment for surrogacy and found that the "supple dried up". Clearly, the main motivation for adoption brokers and medical doctors alike is money. It is a business. Once we acknowledge this we have to deal with property rights - something that even children understand - it's my toy! It's mine because I paid for it and in the market economy transactions involve not just the exchange of goods for money but also the rights to do whatever we please with those goods. If those rights are violated - we can call the police and seek redress from the judicial system. But the baby business is different - it's my car and I can sell it - sure. It's my sperm and I can sell it - OK. It's my blood - it's my kidney - it's my baby - I can sell them. Back off! You can donate your blood and maybe even your kidney - but forget about selling babies - that's not on. Really?

The baby business is indeed a funny business. All the consumer is interested in is the end product - they want a baby but nobody is selling them. Instead people are selling inputs such as sperm or eggs and services. The birth mother in an adoption situation is merely carrying the baby, the agent is facilitating, in the case of IVF the medical doctor is providing an alternative process rather than infertility treatment - everyone is selling services and no one is selling the end product. The laws of demand and supply do not work in this business - willingness to pay continues to be incredibly high. People will do anything to get baby, or the willingness to pay is very high. The story of Rachel and Jacob is telling enough, but Spar writes about a lady who went through 9 cycles of IVF, produced 198 eggs and failed to get pregnant. Prices continue to be high in this market even though scale has increased, so for example the real price of IVF has not fallen in the last 20 years even though the practice has become more prevalent.

All markets need rules - the baby business is no different. Compared to other developed countries the market in the U.S. is relatively unregulated. Rules differ across countries, which leads to arbitrage. People travel across borders to avoid restrictive national rules. Further, regulators need to recognize that all the different avenues from adoption to IVF are substitutes, albeit imperfect, so how you regulate one market has an impact on another. Spar does not deal with the moral issues of the baby business and neither does she judge the market. Instead she suggests alternative regulatory options. These include for example, banning the business altogether, treating it like a luxury good which implies inequitable access and using the donation model as in the case of kidneys, which will lead to shortages and queuing. In addition she calls for a political debate in the U.S., which should address issues relating to access to information, equity, direct and indirect costs and the limits to parental choice.

This is an important an intriguing book, unfortunately it is unlikely to attract the broad readership it deserves. This is because infertility is not a mainstream issue. Having said that however, it will not take much for politicians and the public at large to pay serious attention to the message of this book. What is likely to set off the debate is the link between cloning embryonic stem cells and the market for high tech reproduction no matter how tenuous- all it will take is an eager customer with a very high willingness to pay, an ambitious scientist and a botched experiment.

This review first appeared on a now defunct blog on June 16, 2006